Treatment of Flail Chest
Surgical stabilization of rib fractures (SSRF) should be considered in all flail chest patients as the primary treatment approach. 1
Definition and Clinical Presentation
- Flail chest is a clinical finding characterized by paradoxical movement of a chest wall segment during respiration, resulting from a contiguous segment of 3 or more consecutive ribs fractured at 2 or more places 1
- Patients typically present with rapid breathing, respiratory distress, paradoxical chest wall movement, and may develop shock, especially when combined with pulmonary contusion 1
- This condition is associated with high morbidity and mortality rates, with mortality reaching up to 16% in trauma patients 2
Initial Management
Immediate Stabilization:
- Control paradoxical chest wall movement as soon as possible 1
- Maintain airway patency and provide adequate oxygen supply 1
- Correct respiratory and circulatory dysfunction to prevent shock 1
- For limited or posterior flail segments, apply a pressure dressing with pads temporarily 1
- Consider chest fixation with a multi-head chest strap for immediate stabilization 1
Pain Management:
- Implement aggressive pain control measures, as adequate analgesia is crucial for recovery and restoration of normal respiratory mechanics 3
- Consider regional anesthesia techniques such as intercostal nerve blocks 4
- If pain remains severe despite treatment, this may be an indication for surgical intervention 1
Definitive Treatment Options
1. Surgical Stabilization of Rib Fractures (SSRF)
SSRF is the preferred treatment approach for flail chest patients based on the most recent evidence 1:
Indications for SSRF in flail chest:
- All flail chest patients should be considered for SSRF 1
- Especially beneficial for anterolateral flail segments with displacement 1
- Patients with respiratory failure without severe pulmonary contusion 1
- Patients with pulmonary contusion and persistent chest wall instability or weaning failure 1
- Non-intubated patients with deteriorating pulmonary function 1
Benefits of SSRF compared to non-operative management:
- Lower incidence of tracheostomies (11% vs 37%) 5
- Reduced pneumonia rates (15% vs 50%) 5
- Shorter mechanical ventilation duration (3.9 days vs 15 days) 5
- Decreased ICU stay (9 days vs 21 days) 5
- Lower mortality rates (8% vs 29%) 5
- Better long-term pulmonary function and reduced chest wall deformity 1
- Reduced long-term complaints of chest tightness, pain, and dyspnea 1
- More cost-effective despite the added surgical expense 1
2. Non-Operative Management
For patients who are not candidates for SSRF or when SSRF is not available:
Conservative Respiratory Support:
Mechanical Ventilation:
- Consider for patients with refractory respiratory failure or other serious traumatic injuries 3
- Be aware that prolonged mechanical ventilation is associated with increased pneumonia risk and poorer outcomes 3
- Consider early tracheostomy and frequent flexible bronchoscopy for effective pulmonary toilet in ventilated patients 3
Special Considerations
Pediatric Patients: Surgical management may reduce days of mechanical ventilation and hospitalization in pediatric flail chest cases 6
Pulmonary Contusion: The presence of severe pulmonary contusion may limit the immediate benefits of SSRF on ventilator time and ICU stay 1
Multidisciplinary Approach: SSRF is optimal in dedicated centers with a multidisciplinary team that has developed protocols for both operative and non-operative management 1
Common Pitfalls to Avoid
Focusing only on paradoxical motion: Treatment should address both the chest wall instability and underlying pulmonary contusion 4
Delayed surgical intervention: When indicated, early SSRF provides better outcomes than delayed intervention 1
Prolonged mechanical ventilation: This approach alone is associated with higher rates of pneumonia (50% vs 15%), septicemia (24% vs 4%), and mortality (29% vs 8%) compared to surgical fixation 5
Inadequate pain control: Poor pain management leads to shallow breathing, retained secretions, and increased risk of pneumonia 3